90 related articles for article (PubMed ID: 1336378)
1. Repression of the viral latent promoter BC-R2 in Epstein-Barr virus negative cell lines.
Klonjkowski B; Walls D; Gilardi-Hebenstreit P; Perricaudet M
Biochem Biophys Res Commun; 1992 Dec; 189(3):1695-700. PubMed ID: 1336378
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
Nonkwelo CB; Long WK
Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
[TBL] [Abstract][Full Text] [Related]
3. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
Jansson A; Masucci M; Rymo L
J Virol; 1992 Jan; 66(1):62-9. PubMed ID: 1370095
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
Holley-Guthrie EA; Quinlivan EB; Mar EC; Kenney S
J Virol; 1990 Aug; 64(8):3753-9. PubMed ID: 2164595
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
7. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
Shimizu N; Takada K
J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
Fåhraeus R; Jansson A; Ricksten A; Sjöblom A; Rymo L
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7390-4. PubMed ID: 2170976
[TBL] [Abstract][Full Text] [Related]
10. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
11. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.
Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6498-502. PubMed ID: 2549539
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 5'-upstream sequence of the latent membrane protein 1 (LMP-1) gene of an Epstein-Barr virus identified in nasopharyngeal carcinoma tissues.
Chen ML; Wu RC; Liu ST; Chang YS
Virus Res; 1995 Jun; 37(1):75-84. PubMed ID: 7483824
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Epstein-Barr virus DNA polymerase gene.
Furnari FB; Adams MD; Pagano JS
J Virol; 1992 May; 66(5):2837-45. PubMed ID: 1313904
[TBL] [Abstract][Full Text] [Related]
14. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
15. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.
Nilsson T; Zetterberg H; Wang YC; Rymo L
J Virol; 2001 Jul; 75(13):5796-811. PubMed ID: 11390581
[TBL] [Abstract][Full Text] [Related]
16. Identification of a glucocorticoid-responsive element in Epstein-Barr virus.
Kupfer SR; Summers WC
J Virol; 1990 May; 64(5):1984-90. PubMed ID: 2157866
[TBL] [Abstract][Full Text] [Related]
17. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
20. Identification of the 12-O-tetradecanoylphorbol-13-acetate-responsive enhancer of the MS gene of the Epstein-Barr virus.
Liu Q; Summers WC
J Biol Chem; 1992 Jun; 267(17):12049-54. PubMed ID: 1318308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
